Advertise
NEWSLETTER
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Diagnostic Tools

Cancer blood test maker Grail files for Nasdaq IPO

Temple University Professor Christian Schafmeister, on his commercialisation in the form of his new start-up – ThirdLaw Technologies for spiroligomers.

Building an artificial immune system

A ground-breaking discovery is taking researchers deep into the heart of cells allowing them to measure even the tiniest movements.

Longevity boost as nanotech reveals inner cell workings

A ground-breaking discovery is taking researchers deep into the heart of cells, allowing them to measure

Precious nano metals hold key to new treatments

Precious nano metals hold key to new treatments

Nano medicine - Longevity's greatest revolution might be its smallest

Nanotechnology – Longevity’s small revolution

New technique spots thrombosis in a single drop of blood

Revolutionary nanomaterial heals damage after heart attack giving life extension hope

An eye for an eye as the saying goes - in the future of wearable contact lens technology we will soon be keeping an eye on our health.

Contact lens set to revolutionise medical diagnoses – and lifespan

There are numerous treatments for neurodegenerative diseases, yet one major obstacle to these therapies is the body's efficient brain-blood barrier (BBB).

Blood-brain barrier (BBB) replicated on a chip

Microscopic nano-probe device could be used to diagnose and treat cancer say team of researchers at the University of Toronto.

Magnetic nano-probe explores the inside of human cells

NanoFlares detect cancer biomarkers

Harvard graduate designs AI for TB resistance – and people will live longer as a result

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed